Koyfin Home > Directory > Health Care > Iradimed Cp > Repurchase of Common Stock

Iradimed Cp Repurchase of Common Stock Chart (IRMD)

Iradimed Cp annual/quarterly Repurchase of Common Stock from 2016 to 2020.
  • Iradimed Cp Repurchase of Common Stock for the quarter ending June 06, 2020 was $-1m a 99.84% decrease of -1m year over year
  • Iradimed Cp Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-1m a 62.63% decrease of -1m year over year
  • Iradimed Cp Annual Repurchase of Common Stock for 2019 was $0m a 34.57% decrease of 0m from 2018
  • Iradimed Cp Annual Repurchase of Common Stock for 2018 was $0m a -538.54% increase of 2m from 2017
  • Iradimed Cp Annual Repurchase of Common Stock for 2017 was $-2m a -404.35% increase of 8m from 2016
Other Cash Flow Metrics:
  • Iradimed Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $4m a 55.29% increase of 2m year over year
  • Iradimed Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $2m a 26.43% increase of 1m year over year
  • Iradimed Cp Total Revenue for the quarter ending December 12, 2018 was $8m a 14.76% increase of 1m year over year
View Chart On Koyfin

Quarterly IRMD Repurchase of Common Stock Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual IRMD Repurchase of Common Stock Data

2019$0m
2018$0m
2017$-2m
2016$-10m